| 1 |
32033745 | Targetoid hepatic observations on gadoxetic acid-enhanced MRI using LI-RADS version 2018: emphasis on hepatocellular carcinomas assigned to the LR-M category. | 2020 Jun |
1 |
| 2 |
32166493 | Comparison of diagnostic performance of non-contrast MRI and abbreviated MRI using gadoxetic acid in initially diagnosed hepatocellular carcinoma patients: a simulation study of surveillance for hepatocellular carcinomas. | 2020 Aug |
2 |
| 3 |
27957635 | Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants. | 2017 Aug |
2 |
| 4 |
26130441 | Comparison of gadoxetic acid-enhanced magnetic resonance imaging and contrast-enhanced computed tomography with histopathological examinations for the identification of hepatocellular carcinoma: a multicenter phase III study. | 2016 Jan |
1 |
| 5 |
25203131 | Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings. | 2015 Jan |
1 |
| 6 |
25231411 | Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. | 2015 Mar |
1 |
| 7 |
25668519 | Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics. | 2015 Jun |
1 |
| 8 |
23401584 | Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. | 2013 Jun |
1 |
| 9 |
22847903 | Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis. | 2012 Oct 1 |
2 |
| 10 |
20380933 | Comparison of gadoxetic acid-enhanced MRI and superparamagnetic iron oxide-enhanced MRI for the detection of hepatocellular carcinoma. | 2010 May |
2 |